▲ +19.68% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Outset Medical in the last 3 months. The average price target is $58.20, with a high forecast of $63.00 and a low forecast of $54.00. The average price target represents a 19.68% upside from the last price of $48.63.
The current consensus among 8 contributing investment analysts is to buy stock in Outset Medical.
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It offers Tablo Hemodialysis System, which comprises of a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.